Stock BNR BURNING ROCK BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Burning Rock Biotech Limited

Equities

BNR

US12233L1070

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 02:00:01 27/04/2024 am IST 		5-day change 1st Jan Change
0.85 USD -0.01% Intraday chart for Burning Rock Biotech Limited +18.06% -8.60%
02/04 Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M MT
02/04 Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90 MT

Business Summary

Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The Company mainly conducts its businesses in the China market.

Sales per Business

USD in Million2021Weight2022Weight Delta
Central Laboratory
55.9 %
50 62.9 % 47 55.9 % -5.60%
In-hospital
31.1 %
26 32.5 % 26 31.1 % +1.68%
Pharma Research and Development Services
13.0 %
4 4.6 % 11 13.0 % +199.59%

Sales per region

USD in Million2021Weight2022Weight Delta
China
98.2 %
79 100.0 % 82 98.2 % +4.35%
United States
1.8 %
0 0.0 % 1 1.8 % -

Managers

Managers TitleAgeSince
Simon Wu FOU
 Founder - 01/14/01
Yu Sheng Han CEO
 Chief Executive Officer 46 01/14/01
Leo Li DFI
 Director of Finance/CFO 40 01/19/01
Zhi Hong Zhang CTO
 Chief Tech/Sci/R&D Officer 49 01/16/01
Sharon Liang PRN
 Corporate Officer/Principal - 30/21/30

Members of the board

Members of the board TitleAgeSince
Feng Deng BRD
 Director/Board Member 61 01/16/01
Yu Sheng Han CEO
 Chief Executive Officer 46 01/14/01
Gang Lu BRD
 Director/Board Member 53 01/14/01
Leo Li DFI
 Director of Finance/CFO 40 01/19/01
Wendy Hayes BRD
 Director/Board Member 54 01/18/01
Zhi Hong Zhang CTO
 Chief Tech/Sci/R&D Officer 49 01/16/01
Min-Jui Shen BRD
 Director/Board Member 60 01/20/01
Licen Xu BRD
 Director/Board Member 59 24/22/24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,324,848 0 0 62.79 %
Stock B 1 88,373,682 66,368,583 ( 75.10 %) 3,023,138 ( 3.421 %)

Shareholders

NameEquities%Valuation
Kynam Capital Management LP
10.56 %
8,694,426 10.56 % 6 M $
Massachusetts Financial Services Co.
4.913 %
4,045,110 4.913 % 3 M $
MFS International (UK) Ltd.
4.324 %
3,559,470 4.324 % 3 M $
FIL Investment Services (UK) Ltd.
3.412 %
2,808,981 3.412 % 2 M $
Millennium Management LLC
2.116 %
1,742,028 2.116 % 1 M $
Nikko Asset Management Americas, Inc.
0.8103 %
667,065 0.8103 % 485 623 $
SUMITOMO MITSUI TRUST HOLDINGS, INC.
0.7184 %
591,428 0.7184 % 430 560 $
MFS International Singapore Pte. Ltd.
0.4228 %
348,100 0.4228 % 253 417 $
Renaissance Technologies LLC
0.4194 %
345,300 0.4194 % 251 378 $
Morgan Stanley Capital Services LLC
0.3885 %
319,810 0.3885 % 232 822 $
NameEquities%Valuation
Yu Sheng Han
100.00 %
17,324,848 100.00 % 13 M $
NameEquities%Valuation
Feng Deng
13.52 %
11,880,245 13.52 % 9 M $
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
9.490 %
8,338,381 9.490 % 6 M $
CHINA MERCHANTS BANK CO., LTD.
7.987 %
7,017,385 7.987 % 5 M $
Sequoia Capital
7.792 %
6,846,567 7.792 % 5 M $
LAV Management Co., Ltd.
4.990 %
4,384,205 4.990 % 3 M $
GIC Pte Ltd. (Investment Management)
4.617 %
4,056,400 4.617 % 3 M $
Shao Kun Chuai
2.448 %
2,150,572 2.448 % 2 M $
Yu Sheng Han
0.0309 %
27,175 0.0309 % 19 783 $

Company contact information

Burning Rock Biotech Ltd.

No. 5 Xingdao Ring Road North International Bio Island

510005, Guangzhou

+86 20 3403 7871

http://www.brbiotech.com
address Burning Rock Biotech Limited(BNR)

Sector

Healthcare
Healthcare Services
Healthcare Providers & Services
Healthcare Facilities & Services
Medical & Diagnostic Laboratories

Sales per Business

Sales per region

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
BURNING ROCK BIOTECH LIMITED Stock Burning Rock Biotech Limited
-8.60% 89.62M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.58B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
ADICON HOLDINGS LIMITED Stock Adicon Holdings Limited
-15.34% 1.03B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. BNR Stock
  4. Company Burning Rock Biotech Limited